Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Chemical substance: Melphalan
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Melphalan 2mg tablets
0801010S0AAABAB
|
Melphalan | Melphalan | Malignant Disease and Immunosuppression | 2 |
|
Alkeran 2mg tablets
0801010S0BBAAAB
|
Alkeran | Melphalan | Malignant Disease and Immunosuppression | No data available |
|
Alkeran 50mg inj vials
0801010S0BBADAD
|
Alkeran | Melphalan | Malignant Disease and Immunosuppression | No data available |
|
Alkeran 5mg tablets
0801010S0BBABAC
|
Alkeran | Melphalan | Malignant Disease and Immunosuppression | No data available |
|
Melphalan 50mg inj vials
0801010S0AAADAD
|
Melphalan | Melphalan | Malignant Disease and Immunosuppression | No data available |
|
Melphalan 5mg tablets
0801010S0AAACAC
|
Melphalan | Melphalan | Malignant Disease and Immunosuppression | No data available |
|
Phelinun 50mg pdr and solvent for concentrate for inf vials
0801010S0BCAAAD
|
Phelinun | Melphalan | Malignant Disease and Immunosuppression | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.